Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
Adeleke S, Latifoltojar A, Sidhu H, Galazi M, Shah TT, Clemente J, Davda R, Payne HA, Chouhan MD, Lioumi M, Chua S, Freeman A, Rodriguez-Justo M, Coolen A, Vadgama S, Morris S, Cook GJ, Bomanji J, Arya M, Chowdhury S, Wan S, Haroon A, Ng T, Ahmed HU, Punwani S. Adeleke S, et al. Among authors: chowdhury s. BMC Med Imaging. 2019 Nov 15;19(1):90. doi: 10.1186/s12880-019-0380-y. BMC Med Imaging. 2019. PMID: 31730466 Free PMC article. Clinical Trial.
The role of metastasectomy in renal cell carcinoma.
Josephides E, Rodriguez-Vida A, Galazi M, Chowdhury S, Suder A. Josephides E, et al. Among authors: chowdhury s. Expert Rev Anticancer Ther. 2013 Dec;13(12):1363-71. doi: 10.1586/14737140.2013.856762. Expert Rev Anticancer Ther. 2013. PMID: 24236818 Review.
Cytoreductive nephrectomy: past, present and future.
Galazi M, Rodriguez-Vida A, Josephides E, Chau NM, Chowdhury S. Galazi M, et al. Among authors: chowdhury s. Expert Rev Anticancer Ther. 2014 Mar;14(3):271-7. doi: 10.1586/14737140.2014.864240. Epub 2014 Jan 6. Expert Rev Anticancer Ther. 2014. PMID: 24392671 Review.
Is there an antiandrogen withdrawal syndrome with enzalutamide?
Rodriguez-Vida A, Bianchini D, Van Hemelrijck M, Hughes S, Malik Z, Powles T, Bahl A, Rudman S, Payne H, de Bono J, Chowdhury S. Rodriguez-Vida A, et al. Among authors: chowdhury s. BJU Int. 2015 Mar;115(3):373-80. doi: 10.1111/bju.12826. Epub 2014 Oct 24. BJU Int. 2015. PMID: 24906049
Precision medicine for prostate cancer.
Galazi M, Rodriguez-Vida A, Ng T, Mason M, Chowdhury S. Galazi M, et al. Among authors: chowdhury s. Expert Rev Anticancer Ther. 2014 Nov;14(11):1305-15. doi: 10.1586/14737140.2014.972948. Epub 2014 Oct 30. Expert Rev Anticancer Ther. 2014. PMID: 25354871 Review.
Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment.
Cook GJR, Azad GK, Taylor BP, Lee E, Morrison MS, Hughes S, Morris S, Rudman S, Chowdhury S, Goh V. Cook GJR, et al. Among authors: chowdhury s. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):898-903. doi: 10.1007/s00259-017-3926-7. Epub 2018 Feb 2. Eur J Nucl Med Mol Imaging. 2018. PMID: 29396636 Free PMC article.
HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models.
Gómez V, Galazi M, Weitsman G, Monypenny J, Al-Salemee F, Barber PR, Ng K, Beatson R, Szokol B, Orfi L, Mullen G, Vanhaesebroeck B, Chowdhury S, Leung HY, Ng T. Gómez V, et al. Among authors: chowdhury s. Mol Cancer Ther. 2022 Apr 1;21(4):667-676. doi: 10.1158/1535-7163.MCT-21-0320. Mol Cancer Ther. 2022. PMID: 35086953 Free PMC article.
3,589 results